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Abstract: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Success of
current therapies is still limited and outcome is particularly poor for metastatic alveolar rhabdomyosar-
coma (aRMS). We previously identified the proprotein convertase furin as potential target for specific
drug delivery with RMS-homing peptides. Furin is a protease that converts inactive precursor proteins
into bioactive proteins and peptides. In this study, we investigate the biological role of furin in aRMS
progression in vitro and in vivo. Furin expression was confirmed in over 86% RMS biopsies in a tissue
microarray (n=89). Inducible furin silencing in vitro led to significant impairment of cell viability and
proliferation in all investigated aRMS cell lines, but not in MRC5 fibroblasts. Furthermore, the aRMS
cell lines Rh3 and Rh4 revealed to be very sensitive to furin silencing, undergoing caspase-dependent
cell death. Notably, furin silencing in vivo led to complete remission of established Rh4 tumors and to
delayed growth in Rh30 tumors. Taken together, these findings identify furin as an important factor for
aRMS progression and survival. Thus, we propose furin as a novel therapeutic target for treatment of
aRMS.
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Cardiac amyloidosis: still challenging
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A 67-year-old men complaining of rapidly pro-
gressive dyspnoea was hospitalized with a first
episode of biventricular cardiac decompensation
at a local hospital. Initial evaluation revealed a
hypertrophic ventricle with preserved ejection
fraction, a restrictive filling pattern and dilated at-
ria as well as a diffuse and patchy midventricular
late gadolinium enhancement in MRI (Panel A).
Therefore, some form of hypertrophic or
restrictive cardiomyopathy was suspected. No
signs for systemic diseases were found, particu-
larly not for haemochromocytosis or multiple
myeloma (immune-electrophoresis). Symptom-
atic heart failure treatment was initiated with a
loop diuretic and a follow-up with a cardiologist
was scheduled.
Echocardiography some weeks later showed
symmetrical thickening of the left and right ventri-
cles with normal ejection fraction, an increased
echogenicity with a granular sparkling appear-
ance, as well as dilated and immobile atria (Panel
B; Supplementary material online, Video S1).
Furthermore, LV-inflow pattern, tissue Doppler
images, and pulmonary vein inflow was notable
for severe diastolic dysfunction (restrictive filling
pattern; Panel C). Cardiac amyloidosis was suspected and the patient was referred to the ‘amyloidosis network’ of the University Hospital
Zurich for endomyocardial biopsy. Although cardiac biopsies showed an increased interstitial matrix (Panel D, left), Congo-Red staining
did not show typical green birefringence by polarizing microscopy and immunohistochemical stainings for AL amyloid and transthyretin-
related amyloid were negative. However, in electron microscope the morphology and arrangement of the interstitial fibrils were
characteristic for amyloid (Panel D, right). Typical for amyloidosis, an advanced 3D-echocardiography then clearly demonstrated a
baso-apical gradient with preserved systolic function at the apex, a relative apical sparing in speckle-tracking longitudinal strain pattern
(Panel E; Supplementary material online, Video S2), and decreased LV torsion (Panel F).
These observations prompted to reevaluate initial assessment and recheck for multiple myeloma. Indeed, serum electrophoresis and
bone marrow biopsy revealed a lambda-clonal plasma cell neoplasia, and AL-amyloidosis type lambda was diagnosed. This case illustrates
difficulties diagnosing cardiac amyloidosis and highlights the value and importance of advanced echocardiography in the diagnosis of
cardiac amyloidosis.
Supplementary material is available at European Heart Journal online.
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